Mereo BioPharma Group plc announced the appointment of Richard Francis as Head of Pharmaceutical Development, effective August 1, 2019. Mr. Francis brings to Mereo more than 35 years of experience in biopharmaceutical process development and manufacturing operations across a diverse set of product types including antibodies, recombinant DNA proteins, gene therapy constructs and at all stages of their life cycle development. Prior to joining Mereo BioPharma, Mr. Francis was the owner and senior director of Francis Biopharma Ltd., where he served as an expert CMC consultant to over 30 biopharmaceutical clients, including Mereo.